NeuroPace NPCE
NASDAQ NPCE
$13.05 -0.46 (-3.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

NeuroPace (NPCE) Other Non-Current Liabilities (2020 - 2021)

Updated

NeuroPace (NPCE) recorded Other Non-Current Liabilities of $1.4 million in Q4 2021, down 30.0% from $2 million a year earlier and unchanged from the prior quarter.

Analysis

NeuroPace (NPCE) Other Non-Current Liabilities (2020 - 2021) Analysis & Trends

Starting with Q4 2020, NeuroPace's Other Non-Current Liabilities history includes 5 quarters.

  • Across earlier years, Other Non-Current Liabilities came in at $2 million in FY2020.
  • Quarterly Other Non-Current Liabilities has ranged from $1.4 million in Q3 2021 to $3.49 million in Q1 2021 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $1.4 million (Q3 2021), $1.5 million (Q2 2021) and $3.49 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 NeuroPace 446.43 Mn 219.67 Mn 18.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 3.71 Mn
Sep 30, 2021 2.69 Mn
Jun 30, 2021 2.84 Mn
Mar 31, 2021 6.77 Mn
Dec 31, 2020 3.94 Mn
API Access

NeuroPace Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NPCE&period=max&api_key=YOUR_API_KEY